The new food contains L-DOPA, a precursor to dopamine, which is being used to self-medicate the patient's underlying psychiatric condition or drug side effects. This is important because it does not address the patient's new, life-threatening condition, Sheehan's syndrome (postpartum hypopituitarism), which requires urgent hormone replacement therapy.